References
1. Burge R, Dawson-Hughes B, Soloman DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465-475.
2. Hallberg I, Rosenqvist AM, Kartous L, et al. Health-related quality of life after osteoporotic fractures. Osteoporos Int 2004;15:834-841.
3. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721-739.
4. Barrett-Connor E, Sajjan SG, Siris ES, et al. Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 2008;19:607-613.
5. Cuddihy MT, Gabriel SE, Crowson CS, et al. Osteoporosis intervention following distal forearm fractures: a missed opportunity? Arch Intern Med 2002;162:421-426.
6. Chami G, Jeys L, Freudman M, et al. Are osteoporotic fractures being adequately investigated? A questionnaire of GP & orthopaedic surgeons. BMC Fam Pract 2006;7:7.
7. Siris ES, Gehlbach S, Adachi JD, et al. Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 2011;22:27-35.
8. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701-1707.
9. Campbell AJ, Reinken J, Allan BC, et al. Falls in old age: a study of frequency and related factors. Age Aging 1981;10:264-270.
10. Fatalities and injuries from falls among older adults--United States, 1993-2003 and 2001-2005. MMWR Morb Mort Wkly Rep 2006;55:1221-1224.
11. Kannus P, Niemi S, Parkkari J, et al. Why is the age-standardized incidence of low-trauma fractures rising in many elderly populations? J Bone Miner Res 2002;17:1363-1367.
12. Kaptoge S, Benevolenekaya LI, Bhalla AK, et al. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from European Prospective Osteoporosis Study. Bone 2005;36:387-398.
13. Cuddihy MT, Gabriel SE, Crowson CS, et al. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int 1999;9:469-475.
14. Hodsman AB, Leslie WD, Tsang JF, et al. 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program. Arch Intern Med 2008;168:2261-2267.
15. Adachi JD, Adami S, Gehlbach S, et al. Impact on prevalent fractures of quality of life: baseline results from the global longitudinal study of osteoporosis in women. Mayo Clin Proc 2010;85:806-813.
16. Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009;301:513-521.
17. Center JR, Nguyen TV, Schneider D, et al. Mortality after all types of osteoporotic fracture in men and women: an observational study. Lancet 1999;353:878-882.
18. Shagina NB, Tolstykh EI, Degteva MO, et al. Cortical bone resorption rate in elderly persons: estimates from long-term in vivo measurements of (90)Sr in the skeleton. Arch Gerontol Geriatr 2012;54:e411-e418.
19. Laib A, Hildebrand T, Hauselmann HJ, et al. Ridge number density: a new parameter for in vivo bone structure analysis. Bone 1997;21:541-546.
20. Stein EM, Liu XS, Nickolas TL, et al. Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res 2010;25:2572-2572.
21. Khosla S, Riggs BL, Atkinson EJ, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res 2006;21:124-131.
22. Dawson-Hughes B, Looker AC, Tosteson AN, et al. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005Y2008. Osteoporos Int 2012;23:811-820.
23. Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:1802-182.
24. Qaseem A, Snow V, Shekelle P, et al. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008;148:680-684.
25. US Preventive Services Task Force. Screening for osteoporosis: US Preventive Services Task Force recommendation statement. Ann Intern Med 2011;154:356-364.
26. Haentjens P, Autier P, Collins J, et al. Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. J Bone Joint Surg Am 2003;85-A:1936-1943.
27. Hughes K, van Beurden E, Eakin EG, et al. Older persons’ perception of risk of falling: implications for fall-prevention campaigns. Am J Public Health 2008;98:351-357.
28. Diamantopoulos AP, Rohde G, Johnsrud I, et al. The epidemiology of low- and high-energy distal radius fracture in middle-aged and elderly men and women in Southern Norway. PLoS One 2012;7:e43367.
29. Mackey DC, Lui LY, Cawthon PM, et al. High-trauma fractures and low bone mineral density in older women and men. JAMA 2007;298:2381-2388.
30. Sanders KM, Pasco JA, Ugoni AM, et al. The exclusion of high-trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res 1998;13:1337-1342.
31. Huntjens KM, Kosar S, van Geel TA, et al. Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int 2010;21:2075-2082.
32. van Helden S, Cals J, Kessels F, et al. Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int 2006;17:348-354.
33. van Geel AC, Geusens PP, Nagtzaam IF, et al. Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective study. BMC Med 2006;4:24.
34. Bessette L, Ste-Marie LG, Jean S, et al. The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int 2008;19:79-86.
35. Black DM, Thompson DE, Bauer DC, et al. Fracture reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 2000;85:4118-4124.
36. Boonen S, Eastell R, Su G, et al. Time to offset of antifracture efficacy and year-by-year persistence of effect of zolidronic acid in women with osteoporosis. J Bone Miner Res 2012;27:1487-1493.
37. Harrington JT, Ste-Marie LG, Brandi ML, et al. Risedronate rapidly reduces the risk of nonvertebral fractures for women with postmenopausal osteoporosis. Calcif Tissue Int 2004;74:129-135.
38. Roux C, Seeman E, Eastell R, et al. Efficacy of residronate on clinical vertebral fractures within six months. Curr Med Res Opin 2004;20:433-439.
39. Oyen J, Gjesdal CG, Brudvik C, et al. Low-energy distal radius fractures in middle-age and elderly men and women--the burden of osteoporosis and fracture risk: a study of 1794 consecutive patients. Osteoporos Int 2010;21:1257-1267.
40. Cranney A, Jamal SA, Tsang JF, et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007;177:575-580.
41. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from Study of Osteoporotic Fractures. J Bone Miner Res 2003;18:1947-1954.
42. Siris ES, Chen YT, Abbott TA, et al. Bone mineral density threshold for pharmacological intervention to prevent fractures. Arch Int Med 2004;164:1108-1112.
43. Mackey DC, Black DM, Bauer DC, et al. Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res 2011;26:2411-2418.
44. Watts NB, Lewiecki EM, Miller PD, et al. National Osteoporosis Foundation 2008 Clinician’s Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist. J Clin Densitom 2008;11:473-477.
46. KijowskiR, TuiteM, Kruger D, et al. Evaluation oftrabecular microarchitecture in nonosteoporotic postmenopausal women with and without fracture. J Bone Miner Res 2012;27:1494-1500.
47. Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000;343:604-610.
48. Boonen S, Reginster JY, Kaufman JM, et al. Fracture risk and zoledronic acid therapy in men with osteoporosis.N Engl J Med 2012;367:1714-1723.
49. Zhong ZM, Chen JT. Anti-fracture efficacy of residronic acid in men: a meta-analysis of randomized controlled trials. Clin Drug Investig 2009;29:349-357.